Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Exp Physiol. 2011 Apr 8;96(6):599–609. doi: 10.1113/expphysiol.2011.057356

Figure 2. Representative tracing of cutaneous thermal hyperaemic in the four treatment sites.

Figure 2

Data are from one representative subject. A) Control; B) L-NAME; C) pretreatment with substance P; and D) substance P plus L-NAME sites. Depicted are the initial peak, nadir, and secondary (NO-dependent) plateau phases. In panels (C) and (D), initial baseline, substance P-induced vasodilatation, and post-infusion baseline are shown.